Natixis Advisors, L.P. Haemonetics Corp Transaction History

Natixis Advisors, L.P.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$81.24 - $97.37 $259,399 - $310,902	3,193 Added 28.69%	14,324 $1.19 Million
Q1 2024 Apr 25, 2024	SELL	$71.24 - $85.35 $333,973 - $400,120	-4,688 Reduced 29.64%	11,131 $950,000
Q4 2023 Feb 06, 2024	BUY	$80.59 - $92.61 $26,111 - $30,005	324 Added 2.09%	15,819 $1.35 Million
Q3 2023 Nov 13, 2023	BUY	$82.56 - $93.49 $120,950 - $136,962	1,465 Added 10.44%	15,495 $1.39 Million
Q2 2023 Aug 15, 2023	BUY	$80.84 - $89.45 $80,193 - $88,734	992 Added 7.61%	14,030 $1.2 Million
Q1 2023 May 11, 2023	BUY	$72.75 - $90.6 $948,514 - $1.18 Million	13,038 New	13,038 $1.08 Million
Q2 2021 Aug 12, 2021	SELL	$51.81 - $118.56 $807,096 - $1.85 Million	-15,578 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$111.01 - $139.48 $304,167 - $382,175	-2,740 Reduced 14.96%	15,578 $1.73 Million
Q4 2020 Feb 12, 2021	SELL	$88.75 - $119.95 $57,155 - $77,247	-644 Reduced 3.4%	18,318 $2.18 Million
Q3 2020 Nov 12, 2020	BUY	$75.65 - $93.58 $1.43 Million - $1.77 Million	18,962 New	18,962 $1.65 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $1.22 Million - $1.55 Million	-13,543 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$71.53 - $95.75 $843,052 - $1.13 Million	-11,786 Reduced 46.53%	13,543 $0
Q1 2018 May 10, 2018	SELL	$60.72 - $74.41 $22,284 - $27,308	-367 Reduced 1.43%	25,329 $1.85 Million
Q4 2017 Feb 14, 2018	BUY	$44.96 - $58.99 $18,928 - $24,834	421 Added 1.67%	25,696 $1.49 Million
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $1.02 Million - $1.13 Million	25,275	25,275 $1.13 Million

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.